Inside the Diagnostics Industry: Quest-hc 1 System Leverages Lab Data to Help Providers Monitor Test Utilization

Getting Medicare and private insurers to pay for lab tests is as challenging as it’s ever been. It’s not just about reimbursement. Payors have become fanatically dedicated to weeding out lab testing … [Read more...]

INDUSTRY TRENDS

Adoption Quickening for Genomic Cancer Testing in Community Settings

Clinicians are increasingly using genomic cancer testing in community health care settings, although there are lingering questions about the utility of results. These are the findings of several … [Read more...]

INDUSTRY TRENDS

Consumers Interested in Raw Genetic Data, Third Party Interpretation Tools

Consumers of direct-to-consumer (DTC) genetic testing download raw data at high rates and frequently use third-party interpretation (TPI) tools, according to a study published June 13 in the American … [Read more...]

INDUSTRY TRENDS

Laboratory Initiation of Cascade Genetic Testing Spurs Uptake

A laboratory-initiated, online effort to reach cancer patients' relatives coupled with discounted genetic tests can increase rates of cascade testing, according to a study published in the January … [Read more...]

EMERGING TESTS

Study Showing PGx Testing Improves Depression Outcomes, Key to Myriad’s Reimbursement Strategy

Pharmacogenomic testing (PGx) provides clinically meaningful improvement in response and remission rates for difficult-to-treat depression patients over standard of care, according to a study … [Read more...]

CAPITAL

Investment Trends: Dx/Tools Venture Capital Keeps Flowing Despite Decline in Early-Stage Investment

Continuing a four-year trend, total U.S. venture capital investment in health care surged in 2018, reaching a new all-time high of $9.6 billion, according to Silicon Valley Bank's (SVB) Trends in … [Read more...]

INDUSTRY TRENDS

Point-of-Care PCR Tests Better Diagnosis, Rx for Kids’ Sore Throats

Given we are still in the midst of cold and flu season, a new study highlights the benefit of point-of-care (POC) polymerase chain reaction (PCR) testing among pediatric patients presenting to the … [Read more...]

INDUSTRY TRENDS

Diagnostics Sector Saw Increased Investment, Exits in 2018

Life science and health care companies had a banner year in 2018, with a record-breaking year for venture capital investment, according to Silicon Valley Bank's Trends in Healthcare Investments and … [Read more...]

INDUSTRY TRENDS

Despite 23andMe Authorization, FDA Cautious About PGx Testing

The U.S. Food and Drug Administration (FDA) provided 23andMe (Mountain View, Calif.) authorization for the first direct-to-consumer (DTC) test for detecting genetic variants that may be associated … [Read more...]

TESTING STRATEGY

FDA Enabling New Point-of-Care Tests for Ebola Outbreak, Flu Season

Several recent U.S. Food and Drug Administration (FDA) actions are bringing point-of-care (POC) infectious disease tests closer to patient care. These recent regulatory wins are enabling more rapid … [Read more...]


(-00000g2)